Clinical Trial Update: Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial of an immunotherapy for advanced prostate cancer completed, with results posted in August 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2016-08-18